#liver cancer

NAFLD is associated with risk factors such as obesity and inflammatory biomarkers and with events including heart attacks and strokes.

Modern antivirals can cure 95% of people with HCV, lowering the risk of cirrhosis, liver cancer and liver failure.

Funding will support research on conditions including fatty liver disease, liver cancer, asthma and chronic kidney disease.

Older people, men and people living in poverty and lacking private insurance were more likely to have active HCV infection.

Generic drugs are cheaper and lead to better treatment compliance compared with brand-name drugs.

The CDC estimates that 21% of people living with HIV also have hepatitis C virus.

However, liver cancer mortality has risen for both Latino men and women.

Drug-related mortality, including overdose, was the leading cause of death.

About 63% of American adults consume at least one or more sugar-sweetened beverages daily.

In 2022, fatty liver disease accounted for nearly a quarter of all liver cancer cases on the transplant waiting list.

About 40% of people worldwide are not aware that viral hepatitis is a leading cause of liver cancer.

Viral hepatitis could kill more people than malaria, tuberculosis and HIV combined if trends continue.

Men, people with obesity and people who smoke are more likely to develop NAFLD.

Lean people had a higher mortality rate despite experiencing fewer metabolic problems.

A “jarringly low” proportion of people with HCV have been tested, treated and cured.